Sakura Finetek U.s.a., Inc.

Sakura Finetek U.S.A., Inc. (doing business as Sakura Finetek USA Inc.), a for-profit manufacturer of histology, pathology, and cytology laboratory equipment headquartered in Torrance, California, supplies specialized medical laboratory instrumentation and maintenance services to federal healthcare and research agencies as a prime contractor on 360 of 362 recent awards (99% prime posture). The company competes exclusively in full-and-open procurements with no set-aside designations across its prime footprint, although one recent small-business set-aside award (valued at $190,125) suggests occasional eligibility consideration.

Sakura Finetek's federal capability portfolio centers on original-equipment-manufacturer (OEM) maintenance, repair, calibration, and preventive-maintenance services for its proprietary Tissue-Tek line of automated slide stainers, vacuum infiltration processors, tissue embedding systems, and automated microtomes deployed across federal pathology and histology laboratories. Representative work includes a $237,566 five-year single-award IDV with the Department of Veterans Affairs Veterans Integrated Service Network 9 (April 2023 through March 2028) for tissue processor maintenance at VA medical centers, generating four delivery orders totaling $395,216 through April 2026 and supporting pathology diagnostic operations. The company also holds a $262,166 indefinite delivery contract through March 2027 (same VISN 9 vehicle) and recently delivered a $75,992 Tissue-Tek VIP 6 AI Vacuum Infiltration Processor to the National Institute of Environmental Health Sciences Comparative and Molecular Carcinogenesis Branch (September 2026) and a $186,500 five-year equipment maintenance contract with CDC Pittsburgh for VIP 6, Prisma Auto Stainers, and AutoSection Automated Microtomes (April 2024 through March 2029). Work is performed at customer locations nationwide (VA medical centers in Tennessee, Arizona, Louisiana, Nevada, North Carolina, Massachusetts, Georgia, and elsewhere) and at the company's Torrance headquarters.

Customer concentration clusters across the Veterans Health Administration (VHA) network. The top five customer agencies by award count (covering 31% of all awards) include Veterans Integrated Service Network 22 (35 awards, $918 thousand combined potential value), the Department of the Navy Bureau of Medicine and Surgery (24 awards, $297 thousand), CDC (19 awards, $532 thousand), Veterans Integrated Service Network 21 (17 awards, $417 thousand), and the Defense Health Agency (16 awards, $910 thousand). By dollar magnitude, the ranking shifts slightly: DOD Uniformed Services University of the Health Sciences anchors the top position at five awards worth $1 million combined, followed by VISN 22 ($918 thousand), Defense Health Agency ($910 thousand), VISN 9 ($835 thousand), and CDC Pittsburgh ($620 thousand). The VHA systems collectively represent roughly one-third of awards by count and account for approximately 40% of the combined potential-value portfolio. The company holds a significant single-award IDV (VA contract 25813D0016) that has generated eight task orders worth $183 thousand combined potential value.

Sakura Finetek works under three named indefinite delivery vehicles: an IDV with VA VISN 9 (eight task orders, $183 thousand combined potential value), a General Services Administration vehicle (AG3A94C080008, five task orders, $96 thousand), and a Department of Defense Uniformed Services University contract (36C24923D0037, four task orders, $395 thousand). Equipment sales and maintenance orders are also issued as standalone purchase orders across federal healthcare facilities, typically on a firm fixed-price basis with completion dates extending five to seven years (reflecting multi-year maintenance agreements and option-year structures). One delivery order valued at $395,216 under the VISN 9 IDV exceeds the stated ceiling of $262,166 by approximately $133,050, suggesting either a ceiling adjustment not reflected in the source or accumulated orders beyond the original constraint.

Activity has declined modestly: the company received five awards in 2022, ramped to thirteen in 2024, then dropped to seven in 2025 and five in 2026 (through late September). Eleven awards with ultimate completion dates in the next twenty-four months carry combined potential value of $856 thousand and face recompete risk. The company rarely subcontracts; sub-awards represent only 1% of the recent portfolio (two awards). Work is categorized primarily under NAICS codes for other electronic and precision equipment repair and maintenance (110 awards) and medical, dental, and hospital equipment and supplies merchant wholesale (62 awards), with PSC codes dominated by maintenance and repair of medical, dental, and veterinary equipment (135 awards) and maintenance and repair of instruments and laboratory equipment (75 awards). Combined potential value across all 362 awards totals $9.2 million, with $5.8 million (64%) obligated to date.